Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world

Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world

Source: 
Stat
snippet: 

Novartis and the Bill and Melinda Gates Foundation are joining forces to discover and develop a gene therapy to cure sickle cell disease with a one-step, one-time treatment that is affordable and simple enough to treat patients anywhere in the world, especially in sub-Saharan Africa where resources may be scarce but disease prevalence is high.